1. Home
  2. IRT vs IRON Comparison

IRT vs IRON Comparison

Compare IRT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independence Realty Trust Inc.

IRT

Independence Realty Trust Inc.

HOLD

Current Price

$16.97

Market Cap

3.9B

Sector

Real Estate

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$91.22

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRT
IRON
Founded
2009
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
IRT
IRON
Price
$16.97
$91.22
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
$21.56
$108.83
AVG Volume (30 Days)
2.6M
560.9K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
4.02%
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$662,924,000.00
N/A
Revenue This Year
$4.19
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
$185.79
N/A
Revenue Growth
3.19
N/A
52 Week Low
$15.07
$30.82
52 Week High
$21.89
$99.50

Technical Indicators

Market Signals
Indicator
IRT
IRON
Relative Strength Index (RSI) 56.31 53.55
Support Level $16.32 $90.40
Resistance Level $17.14 $94.51
Average True Range (ATR) 0.32 3.70
MACD -0.01 -0.59
Stochastic Oscillator 68.80 33.04

Price Performance

Historical Comparison
IRT
IRON

About IRT Independence Realty Trust Inc.

Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: